companies developing glp 1 drugs Agonist Clinical Trial Pipeline Appears Robust With 20+ GLP-1 Market Size, Scope, Forecast
Description
Here, in a small room at the US National Institutes of Health (NIH), scientists are harnessing the taproom ambience to study whether blockbuster anti-obesity drugs might also curb alcohol cravings
In May 2022, Lillys Mounjaro (tirzepatide) bagged FDA approval as the first and only approved dual agonist for the treatment of T2DM
Its naturally present in a healthy gut, but its levels decline with poor diet, stress, antibiotics, aging, and other modern lifestyle factors
MET = metformin
PubMed CrossRef Carmellini P, Cuomo A, Rescalli MB, et al
